Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Reverie Labs developed advanced machine learning platforms that accelerate preclinical drug development by optimizing lead generation with a focus on kinase inhibitors. As of May 2023, they had four candidates in various stages from early discovery through IND-enabling. Their technology integrates multi-objective optimization balancing potency with pharmacokinetic properties. Post-acquisition by Ginkgo Bioworks, their platform is being integrated into broader AI-driven biology engineering efforts.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Reverie Labs.